Cancer Medicines Outcomes Programme Public Health Scotland (CMOP-PHS) report for the Scottish Medicines Consortium (SMC)
Systemic anti-cancer therapy (SACT) for adults with relapsed or refractory follicular lymphoma after two or more lines of SACT: SMC2881
Management information
- Published
- 26 May 2026 (Latest release)
- Type
- Statistical report
- Author
- Public Health Scotland
About this release
This release by Public Health Scotland (PHS) uses information from the National SACT dataset.
This work was requested by the Scottish Medicines Consortium (SMC) to support their decision-making processes. Epcoritamab as monotherapy for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of SACT (SMC2881), is being assessed for use by NHS Scotland.
The aim of this work was to capture real-world evidence (RWE) from Scotland on the use of systemic anti-cancer therapy (SACT) for adults with relapsed or refractory FL after two or more lines of SACT. Details of the presumptions made to identify this cohort are described in Section 2.3.1 of the main report. This work will enable SMC members to assess the relevance of information provided as part of the assessment process for epcoritamab (SMC2881), to patients in Scotland.
The objectives were to:
- Determine the number of patients receiving SACT for the treatment of relapsed or refractory FL after two or more lines of SACT.
- Describe the baseline characteristics of patients receiving SACT for the treatment of relapsed or refractory FL after two or more lines of SACT.
General enquiries
If you have an enquiry relating to this publication, please contact David Martin at david.martin6@nhs.scot.
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.
Older versions of this publication
Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.